1. Home
  2. CXT vs TMDX Comparison

CXT vs TMDX Comparison

Compare CXT & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crane NXT Co.

CXT

Crane NXT Co.

HOLD

Current Price

$43.87

Market Cap

3.1B

Sector

Industrials

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$113.83

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXT
TMDX
Founded
1855
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.4B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
CXT
TMDX
Price
$43.87
$113.83
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$76.75
$148.22
AVG Volume (30 Days)
679.4K
934.6K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
1.66%
N/A
EPS Growth
N/A
382.18
EPS
2.50
4.87
Revenue
$3,374,900,000.00
$605,494,000.00
Revenue This Year
$5.69
$24.51
Revenue Next Year
$4.28
$18.72
P/E Ratio
$17.31
$22.43
Revenue Growth
6.13
37.13
52 Week Low
$39.23
$81.92
52 Week High
$69.00
$156.00

Technical Indicators

Market Signals
Indicator
CXT
TMDX
Relative Strength Index (RSI) 51.68 48.57
Support Level $39.62 $109.43
Resistance Level $61.93 $131.86
Average True Range (ATR) 1.62 5.39
MACD 0.61 1.73
Stochastic Oscillator 87.31 78.08

Price Performance

Historical Comparison
CXT
TMDX

About CXT Crane NXT Co.

Crane NXT Co is a industrial technology company that provides proprietary and trusted technology solutions to secure, detect, and authenticate what matters to its customers. It is a pioneer in proprietary micro-optics technology for securing physical products, and its sophisticated electronic equipment and associated software leverages proprietary core capabilities with detection and sensing technologies. The company operates in two segments which are Crane Payment Innovations (CPI) and Security and Authentication Technologies.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: